SKAN Group AGXSWX:SKAN +2.16%82 Days Payable is 135.81 as of Dec. 2025, which is 4% above its 10-year median of 130.54. GuruFocus rates XSWX:SKAN with a GF Score™ of 82/100 and a GF Value™ of CHF85.80 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 793 Medical Devices & Instruments companies, SKAN Group AG ranks better than 79.32% on this metric.
The historical rank and industry rank for SKAN Group AG's Days Payable or its related term are showing as below:
XSWX:SKAN'
s Days Payable Range Over the Past 10 Years
Min: 108.9 Med: 130.54 Max: 177.74
Current: 162.73
During the past 6 years, SKAN Group AG's highest Days Payable was 177.74. The lowest was 108.90. And the median was 130.54.
XSWX:SKAN's Days Payable is ranked better than 79.32% of 793
companies
in the Medical Devices & Instruments industry
Industry Median: 67.83
vs XSWX:SKAN: 162.73
SKAN Group AG's Days Payable
increased
from Dec. 2024 (78.89) to Dec. 2025 (135.81).
It may suggest that SKAN Group AGdelayed paying its suppliers.
SKAN Group AG Days Payable Related Terms
SKAN Group AG Days Payable Historical Data
* Premium members only.
The historical data trend for SKAN Group AG's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:SKAN vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, SKAN Group AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SKAN Group AG Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SKAN Group AG's Days Payable distribution charts can be found below:
* The bar in red indicates where SKAN Group AG's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
SKAN Group AG's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SKAN Group AG (XSWX:SKAN) has a Days Payable of 135.81 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on SKAN Group AG and its competitors. This is near median its historical median of 130.54. Over the past decade, SKAN Group AG's Days Payable has ranged from 108.90 to 177.74. According to the industry distribution chart, SKAN Group AG ranks #164 out of 793 companies in the Medical Devices & Instruments industry, placing it in the top 20.7%.
Is SKAN Group AG's Days Payable too high?
SKAN Group AG's current Days Payable of 135.81 is near median its 10-year median of 130.54. Over the past 10 years, this metric has ranged from a low of 108.90 to a high of 177.74. The Medical Devices & Instruments industry median Days Payable is 67.83. SKAN Group AG's value of 135.81 is 100.2% above this industry median. Based on the distribution chart, SKAN Group AG ranks #164 out of 793 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, SKAN Group AG has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SKAN Group AG's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, SKAN Group AG ranks #164 out of 793 companies for Days Payable. This places SKAN Group AG in the top 21% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.83. SKAN Group AG's value of 135.81 is 100.2% above this benchmark. Historically, SKAN Group AG's own Days Payable has ranged from 108.90 to 177.74 over the past decade. While the company's 10-year median is 130.54 vs. the industry median of 67.83, SKAN Group AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.83, based on 793 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SKAN Group AG's current Days Payable of 135.81 is 100.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on SKAN Group AG and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SKAN Group AG's current Days Payable is 135.81, which is near median its own 10-year median of 130.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SKAN Group AG stock overvalued right now?
Based on GuruFocus' analysis, SKAN Group AG (XSWX:SKAN) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF85.80, compared to a current price of CHF56.80 — trading 33.8% below its estimated fair value. The current Days Payable is 135.81, which is near median its 10-year median of 130.54 and 100.2% above the Medical Devices & Instruments industry median of 67.83. SKAN Group AG's overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For SKAN Group AG (XSWX:SKAN), the current Days Payable is 135.81 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SKAN Group AG (XSWX:SKAN) Overvalued in 2026?
Based on GuruFocus' analysis, SKAN Group AG stock appears to be undervalued.
The current stock price of CHF56.80 is trading 33.8% below its estimated GF Value™ of CHF85.80.
GuruFocus considers SKAN Group AG to be Significantly Undervalued.
Key valuation signals for XSWX:SKAN:
Days Payable: 135.81 (near median its 10-year median of 130.54)
GF Value™: CHF85.80 vs. price of CHF56.80 (33.8% below fair value)
Industry Position: 100.2% above the Medical Devices & Instruments median (#164 of 793)
No single metric tells the full story. See the XSWX:SKAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SKAN Group AG is a market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. The company offers its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbenches, transfer systems, and others. The Firm has three operating segments: Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically, the company derives revenue from Asia, Europe, Americas, and Other regions.
82GF Score
Get the complete analysis for XSWX:SKAN
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SKAN has been successfully added to your 
